National assessment
A structured baseline covering disease burden, referral pathways, workforce, infrastructure, financing and delivery constraints.
Output: evidence base and prioritised investment caseFor ministries · agencies · public institutions
Institutional partnerships designed for public accountability.
Durckheim AB helps governments translate oncology priorities into structured, measurable and investment-ready programmes while national institutions retain authority, ownership and long-term responsibility.
Investment discipline
One national vision. Four controlled stages.
The pathway is intentionally staged. Each stage gives government a clear basis to approve, adjust or pause before moving forward.
Scope, responsibilities, budgets, assumptions and success measures are recorded from the outset and reviewed throughout delivery.
Programme architecture
A costed roadmap defining clinical scope, workforce, technology, governance, procurement interfaces and implementation milestones.
Output: government-approved programme designManaged implementation
Coordinated education, clinical development and implementation support with named responsibilities and documented decision gates.
Output: operational services and trained teamsAssurance and transfer
Quality review, outcome monitoring and progressive transfer of programme leadership to national institutions.
Output: durable locally governed capabilityProtection of public value
Governance is part of the programme—not an appendix.
The final governance architecture is adapted to national law, procurement rules and institutional mandates.
Governance
Joint steering structure with defined authority, escalation and reporting lines.
Financial control
Milestone-linked budgets, transparent scope control and auditable documentation.
Clinical quality
Evidence-based pathways, multidisciplinary review and measurable quality indicators.
Sustainability
Train-the-trainer models, local leadership and lifecycle planning for technology.
Risk management
Maintained risk register with owners, mitigations and scheduled government review.
Independence
Technology-neutral planning and explicit management of potential conflicts of interest.
Reporting that serves decisions
Measure capability, quality and access.
Workforce trained, competency achieved and local trainers established.
Clinical pathways adopted, multidisciplinary practice and safety indicators.
Referral performance, time to diagnosis, treatment reach and geographic equity.
Local leadership, operating readiness, maintenance and long-term financing.
Institutional briefing
Bring us your national priority.
An initial confidential discussion clarifies the national health objective, institutional mandate, decision pathway and evidence required for the next formal step.
For official enquiries
contact@durckheim.com559320-4752 · Östersund, SwedenRequest a confidential briefing↗